Detalhe da pesquisa
1.
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab.
Cell
; 171(4): 934-949.e16, 2017 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29033130
2.
Identifying transcriptional profiles and evaluating prognostic biomarkers of HIV-associated diffuse large B-cell lymphoma from Malawi.
Mod Pathol
; 33(8): 1482-1491, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32080349
3.
A pan-cancer analysis of PBAF complex mutations and their association with immunotherapy response.
Nat Commun
; 11(1): 4168, 2020 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32820162
4.
Tumor mutational load predicts survival after immunotherapy across multiple cancer types.
Nat Genet
; 51(2): 202-206, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30643254
5.
Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy.
Science
; 359(6375): 582-587, 2018 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29217585
6.
Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapy.
Nat Genet
; 48(11): 1327-1329, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27668655